Immix Biopharma, Inc
Price
FilingsNewest: 8-K, Other eventsSep 30 →Insiders2 insiders bought $10,042 in 2 open-market buys. No sales.→HoldersJupiter Topco 13.7%Saturn V 6.5%Eventide 5.4%→Financing →PeersClosest companies: BNTC, MNPR, HURA→
From the filings
Figures
- Net income
- −$39.9Mlast 12 months
- Operating cash flow
- −$32.1Mlast 12 months
- Cash and equivalents
- $225.5Mat the last balance sheet
- Shares outstanding
- 71.5M shareson issue